Viewing Study NCT01824303


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-02-17 @ 8:10 PM
Study NCT ID: NCT01824303
Status: TERMINATED
Last Update Posted: 2016-01-26
First Post: 2013-03-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability and Efficacy Study of LiRISĀ® 400 mg in Women With Interstitial Cystitis
Sponsor: Allergan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Interstitial Cystitis View
Keywords: